Data / Form D filings / Merus N.V.
Merus N.V.: Form D filings
Merus N.V., a biotechnology company in 3584 Cm Utrecht, Netherlands, filed 3 Form D notices with the SEC between 2017 and 2019. The latest, on January 2, 2019, reports $15 million sold of a $15 million offering to 1 investor.
Find out what Merus N.V. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- YALELAAN 62, 3584 Cm Utrecht, Netherlands, 3584
- Phone
- 31 030 253 8800
- Industry
- Biotechnology
- Entity type
- Other (a public company with limited liability, incorporated under the laws of the Netherlands)
- Incorporated in
- Netherlands
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1651311
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 2, 2019 | New notice | $15,000,000 | $15,000,000 | $0 | 1 | Dec 20, 2018 | sec.gov |
| Feb 28, 2018 | New notice | $55,799,946 | $55,799,946 | $0 | 9 | Feb 15, 2018 | sec.gov |
| Jan 24, 2017 | New notice | $80,000,000 | $80,000,000 | $0 | 1 | Jan 23, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ton T. Logtenberg | Executive Officer, Director | |
| Gregory D. Perry | Director | |
| Lex Andres Bakker | Executive Officer | |
| Anand D. Mehra | Director | |
| Mark Andres Throsby | Executive Officer | |
| Russell Andres Greig | Director | |
| Mark T. Iwicki | Director | |
| John Andres De Kruif | Executive Officer | |
| John P. de Koning | Director | |
| Len T. Kanavy | Director | |
| Hui Andres Liu | Executive Officer | |
| L. Andres Sirulnik | Executive Officer | |
| Peter Andres Silverman | Executive Officer |
Every Form D from the week of Dec 31, 2018 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Merus N.V. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.